• About us
  • Products
    • Mammowave
    • Brainwave
  • Projects
    • MammoWave – H2020
    • Rover H2020
    • MammoScreen – HORIZON
    • RadioSpin – H2020
  • News
  • Resources
    • Publications
    • Media
    • Awards
  • Contact us
  • Contact us
          • English
          • Italian
  • English
    • Italiano (Italian)

MammoWave – H2020

Duration: October 2018; 24 months (extended to 35 months, due to pandemic)

UBT has been awarded a SME Instrument Phase 2 grant of €1.4 million under grant agreement No. 830265. Within such SME Instrument project, UBT further developed and tested MammoWave, the innovative x-rays free microwave mammogram. MammoWave has be used in an international clinical study involving prestigious hospitals in Italy, Spain and Germany. What is the SME Instrument? The SME Instrument is a programme under the Horizon 2020 framework run by the EASME, the European Executive Agency for Small and Medium-sized Enterprises. UBT already secured a Phase 1 SME Instrument grant in 2017. The Phase 2 project continued the work started in Phase 1 and

allowed UBT to achieve key milestones such as:

• Development of an interoperable application for MammoWave imaging;
• Proving MammoWave large scale manufacturability and assembly repeatability;
• achieving CE marking;
• ISO 13485;
• validating MammoWave’s performances in international clinical study.

The international clinical study has been successfully performed at:

• Hospital Virgen de la Salud, Toledo, Spain;
• Ospedale Policlinico San Martino, Genova, Italy;
• Humanitas Research Hospital, Milano, Italy.


Clinical trial is based on the protocol “A multicentric, single arm, prospective, stratified clinical investigation to evaluate the ability of MammoWave in breast lesions detection”, which has been finalized in collaboration with the C.R.O: MTA – Medical Trials Analysis. Clinical trial has been registered at ClinicalTrials.gov: Enrollment has been successfully completed in August 2021.

Informations
Project:

Cutting edge microwave imaging device for safe and accurate breast cancer screening (MammoWave)

Grant agreement:

SME Instrument Phase 2 - 830265

Call:
EIC-SMEInst-Phase 2
Acknowledgment:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme

INTERESTED IN OUR DEVICE FOR YOUR HOSPITAL OR YOUR CLINIC?

Do not hesitate to contact us. We will be happy to inform you about our innovative medical devices

Contact us

Useful Links

  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
  • Home
  • News
  • Contact us
  • Privacy policy
  • Cookie Policy
45055_st_francis_md

UBT Srl

Santa Maria della Spina Str., 25
06081 Rivotorto di Assisi (PG) Italy

VAT: 03434740548

Tel: +39 3490564302
gianluigi@ubt-tech.com (Scientific)
g.raspa@ubt-tech.com (Hardware)
s.tiberi@ubt-tech.com (Business)
amministrazione@ubt-tech.com (Administration)

london2

UBT UK Division

3rd Floor 207 Regent Street, London, W1B 3HH (Registered)
103 Borough Rd, London, SE1 0AA (Operational)

Company number 13096679

Tweets by UBTsrl
Linkedin Twitter Youtube

According to the Italian Ministry of Health guidelines of 28/03/2013, the information contained in this website is exclusively intended for professional operators.

© 2023UBT S.r.l. All Rights Reserved.